U.S. Markets open in 7 hrs 6 mins
  • S&P Futures

    3,810.00
    -6.75 (-0.18%)
     
  • Dow Futures

    31,218.00
    -18.00 (-0.06%)
     
  • Nasdaq Futures

    12,656.00
    -25.75 (-0.20%)
     
  • Russell 2000 Futures

    2,199.70
    -6.10 (-0.28%)
     
  • Crude Oil

    61.83
    +0.55 (+0.90%)
     
  • Gold

    1,719.20
    +3.40 (+0.20%)
     
  • Silver

    26.28
    -0.10 (-0.39%)
     
  • EUR/USD

    1.2057
    -0.0010 (-0.0844%)
     
  • 10-Yr Bond

    1.4700
    0.0000 (0.00%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3959
    +0.0006 (+0.0433%)
     
  • USD/JPY

    107.1200
    +0.1180 (+0.1103%)
     
  • BTC-USD

    49,747.37
    +931.98 (+1.91%)
     
  • CMC Crypto 200

    997.03
    +8.94 (+0.90%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

New Strong Sell Stocks for November 19th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Fennec Pharmaceuticals Inc. FENC is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 5% downward over the last 30 days.

Aileron Therapeutics, Inc. ALRN is focused on developing and commercializing a novel class of stabilized cell-permeating alpha-helical peptides in the oncology and other therapeutic areas in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.

Celsion Corporation CLSN is an integrated development clinical stage oncology drug company. The Zacks Consensus Estimate for its current year earnings has been revised 7.9% downward over the last 30 days.

eMagin Corporation EMAN is a designer and manufacturer of organic light emitting diode (OLED) displays on-silicon micro displays; virtual imaging products that utilize OLED micro displays; and related products. The Zacks Consensus Estimate for its current year earnings has been revised 30.8% downward over the last 30 days.

Mercury General Corporation MCY is engaged in writing personal automobile insurance in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 4.1% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Celsion Corporation (CLSN) : Free Stock Analysis Report
 
eMagin Corporation (EMAN) : Free Stock Analysis Report
 
Mercury General Corporation (MCY) : Free Stock Analysis Report
 
Adherex Technologies Inc. (FENC) : Free Stock Analysis Report
 
Aileron Therapeutics, Inc. (ALRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research